Largest pharmaceutical companies in the United States by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

AbbVie leads the 24 pharmaceutical companies in the United States ranked by total debt, at SGD 87B, ahead of Pfizer (SGD 83.5B) and Merck & Co (SGD 63.6B). Figures as of 20 Nov 2026, 16:20 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AbbVieSGD 87B
Median
SGD 3B
Combined market value
SGD 4.85T
Countries
1
Not ranked
20no total debt on file

Market values as of .

United States
All sectors
Pharmaceuticals
SGD
Clear filters
Largest pharmaceutical companies in the United States by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AbbVieABBV · Health CareSGD 87BSGD 655.8BSGD 371.00 1.48% up 20% up United States
2PfizerPFE · Health CareSGD 83.5BSGD 203.6BSGD 35.71 0.58% up 10% up United States
3Merck & CoMRK · Health CareSGD 63.6BSGD 430.9BSGD 174.80 2.08% up 36% up United States
4Johnson & JohnsonJNJ · Health CareSGD 61.8BSGD 841.1BSGD 349.41 1.44% up 31% up United States
5Bristol-Myers SquibbBMY · Health CareSGD 58.2BSGD 156.5BSGD 76.54 1.76% up 26% up United States
6Eli LillyLLY · Health CareSGD 54.8BSGD 1.55TSGD 1,745.04 0.17% up 28% up United States
7ViatrisVTRS · Health CareSGD 18.6BSGD 29BSGD 25.27 1.41% down 90% up United States
8Abbott LaboratoriesABT · Health CareSGD 16.7BSGD 232.6BSGD 134.32 0.30% up 19% down United States
9ZoetisZTS · Health CareSGD 11.7BSGD 42.5BSGD 104.72 0.53% up 34% down United States
10Royalty PharmaRPRX · Health CareSGD 11.5BSGD 50.7BSGD 88.14 0.95% up 74% up United States
11Elanco Animal HealthELAN · Health CareSGD 5.2BSGD 16.8BSGD 33.56 0.99% down 18% up United States
12Amneal PharmaceuticalsAMRX · Health CareSGD 3.3BSGD 9.5BSGD 27.36 0.79% down 79% up United States
13BridgeBio PharmaBBIO · Health CareSGD 2.6BSGD 19.4BSGD 99.63 1.16% down 15% up United States
14Regeneron PharmaceuticalsREGN · Health CareSGD 2.6BSGD 124.5BSGD 1,203.35 1.18% up 22% up United States
15Ionis PharmaceuticalsIONS · Health CareSGD 2.3BSGD 5.9BSGD 35.38 0.81% up 64% down United States
16InsmedINSM · Health CareSGD 705MSGD 41.4BSGD 188.58 1.25% up 27% down United States
17Madrigal PharmaceuticalsMDGL · Health CareSGD 438.2MSGD 11.7BSGD 502.12 1.84% down 28% down United States
18Legend BiotechLEGN · Health CareSGD 411.4MSGD 4BSGD 20.40 1.74% down 43% down United States
19CytokineticsCYTK · Health CareSGD 370.8MSGD 9.4BSGD 67.16 1.22% up 21% down United States
20TG TherapeuticsTGTX · Health CareSGD 316.7MSGD 12.6BSGD 83.39 0.32% down 103% up United States
21Cogent BiosciencesCOGT · Health CareSGD 287.4MSGD 6.1BSGD 34.92 2.36% down 25% down United States
22Axsome TherapeuticsAXSM · Health CareSGD 242.1MSGD 8.9BSGD 169.10 3.34% down 9% down United States
23Rhythm PharmaceuticalsRYTM · Health CareSGD 139.5MSGD 10.2BSGD 146.68 2.60% down 15% up United States
24Definium TherapeuticsDFTX · Health CareSGD 52.3MSGD 5.2BSGD 37.66 0.92% down 176% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2893 SGD). 20 companies have no total debt on file and are not ranked here.

Questions and answers

Which pharmaceutical companies in the United States rank first by total debt?

AbbVie (SGD 87B), Pfizer (SGD 83.5B) and Merck & Co (SGD 63.6B) are the top three of the 24 pharmaceutical companies in the United States ranked by total debt as of 20 Nov 2026, 16:20 UTC.

How many pharmaceutical companies in the United States are in this ranking?

24 are ranked by total debt. 20 more have no total debt on file and are left out rather than ranked at zero.

What are these pharmaceutical companies in the United States worth together?

The 24 pharmaceutical companies in the United States ranked by total debt have a combined market value of SGD 4.85T as of 20 Nov 2026, 16:20 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest pharmaceutical companies in the United States by total debt”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.